HG106
HG106 is an effective SLC7A11 inhibitor. HG106 mediates apoptosis by increasing oxidative stress and endoplasmic reticulum stress, and it has antitumor activity[1].
Product Specifications
CAS Number
[928712-10-1]
UNSPSC
12352005
Hazard Statement
H302, H315, H318, H335
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hg106.html
Concentration
10mM
Purity
99.95
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(NC1=CC2=NN(C3=CC=C(OC)C=C3)N=C2C=C1)CCl
Molecular Formula
C15H13ClN4O2
Molecular Weight
316.74
Precautions
H302, H315, H318, H335
References & Citations
[1]Hu K, et al. Suppression of the SLC7A11/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma. J Clin Invest. 2020 Apr 1;130 (4) :1752-1766.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15096908 1 Vial
Lentiviral human LEMD1 shRNA (UAS) - Lentiviral human LEMD1 shRNA (UAS, GFP) (25)
Ask
View Details 